海外の治験の状況「前立腺癌」での検索結果
3007件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Ipilimumab and GMCSF Immunotherapy for Prostate Cancer
- Prostate Cancer
- United States
- 2012-02-07
Not recruiting
- Tivantinib in Treating Patients With Metastatic Prostate Cancer
- Hormone-Resistant Prostate Cancer;Prostate Adenocarcinoma;Recurrent Prostate Carcinoma;Stage IV Prostate Cancer;Hormone-Resistant Prostate Cancer;Prostate Adenocarcinoma;Recurrent Prostate Carcinoma;Stage IV Prostate Cancer;Hormone-Resistant Prostate Cancer;Prostate Adenocarcinoma;Recurrent Prostate Carcinoma;Stage IV Prostate Cancer;Hormone-Resistant Prostate Cancer;Prostate Adenocarcinoma;Recurrent Prostate Carcinoma;Stage IV Prostate Cancer
- United States
- 2012-01-25
Not recruiting
- Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA
- Prostate Cancer
- United States
- 2012-01-23
Not recruiting
- Radiation and Androgen Ablation for Prostate Cancer
- Adenocarcinoma of the Prostate
- United States
- 2012-01-20
Not recruiting
- Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
- Prostate Cancer
- United States
- 2012-01-17
Not Recruiting
- A clinical study in prostate cancer using a monoclonal antibody
- subjects with asymptomatic or mildly symptomatic metastatic castrate-resistant prostate cancer (mCRPC) MedDRA version: 14.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: LLT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, Germany, Netherlands, Russian Federation, Slovakia, South Africa, Spain, United States
- 2011-01-19
Authorised
- SAFETY, ABSORPTION AND DISTRIBUTION OF ODM-201 IN PATIENTS WITH PROSTATE CANCER:
- Progressive castration resistant prostate cancer (MedDRA: hormone-refractory prostate cancer) MedDRA version: 14.1 Level: LLT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Czech Republic, Finland, France, United Kingdom, United States
- 2010-11-15
Authorised
- SAFETY AND TOLERABILITY OF ODM-201 IN PATIENTS WITH PROSTATE CANCER: EXTENSION STUDY TO STUDY 3104001
- Progressive castration resistant prostate cancer (MedDRA: hormone-refractory prostate cancer) MedDRA version: 14.1 Level: LLT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Czech Republic, Finland, France, United Kingdom, United States
- 2010-11-15
Not recruiting
- Treatment Preference and Patient Centered Prostate Cancer Care
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- United States
- 2013-12-23
Not recruiting
- Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer;Prostate Cancer;Cancer of the Prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-12-03